Literature DB >> 10995236

Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex.

M K Lawless-Delmedico1, P Sista, R Sen, N C Moore, J B Antczak, J M White, R J Greene, K C Leanza, T J Matthews, D M Lambert.   

Abstract

The Respiratory Syncytial Virus (RSV) fusogenic glycoprotein F(1) was characterized using biochemical and biophysical techniques. Two heptad-repeat (HR) regions within F(1) were shown to interact. Proteinase-K digestion experiments highlight the HR1 region (located proximal to the fusion peptide sequence) of the F(1) protein to which an HR2-derived (located proximal to the membrane-spanning domain) peptide binds, thus protecting both the protein and peptide from digestion. Solution-phase analysis of HR1-derived peptides shows that these peptides adopt helical secondary structure as measured by circular dichroism. Sedimentation equilibrium studies indicate that these HR1 peptides self-associate in a monomer/trimer equilibrium with an association constant of 5.2 x 10(8) M(-2). In contrast, HR2-derived peptides form random monomers in solution. CD analysis of mixtures containing peptides from the two regions demonstrate their propensity to interact and form a very stable (T(m) = 87 degrees C), helical (86% helicity) complex comprised of three HR1 and three HR2 members.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995236     DOI: 10.1021/bi000471y

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.

Authors:  T A Sergel; L W McGinnes; T G Morrison
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

Authors:  Margarita Magro; David Andreu; Paulino Gómez-Puertas; José A Melero; Concepción Palomo
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

3.  Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion.

Authors:  Christopher Cianci; David R Langley; Douglas D Dischino; Yaxiong Sun; Kuo-Long Yu; Anne Stanley; Julia Roach; Zhufang Li; Richard Dalterio; Richard Colonno; Nicholas A Meanwell; Mark Krystal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-06       Impact factor: 11.205

4.  Design of an engineered N-terminal HIV-1 gp41 trimer with enhanced stability and potency.

Authors:  John J Dwyer; Karen L Wilson; Kimberly Martin; Jennifer E Seedorff; Aisha Hasan; Robyn J Medinas; Donna K Davison; Michael D Feese; Hans-Thomas Richter; Hidong Kim; Thomas J Matthews; Mary K Delmedico
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

5.  HRA2pl peptide: a fusion inhibitor for human metapneumovirus produced in tobacco plants by transient transformation.

Authors:  Verónica A Márquez-Escobar; Rocío Tirado-Mendoza; Daniel E Noyola; Abel Gutiérrez-Ortega; Ángel G Alpuche-Solís
Journal:  Planta       Date:  2015-04-01       Impact factor: 4.116

6.  Structural characterization of the human respiratory syncytial virus fusion protein core.

Authors:  X Zhao; M Singh; V N Malashkevich; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.

Authors:  Gabriella Cseke; David W Wright; Sharon J Tollefson; Joyce E Johnson; James E Crowe; John V Williams
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

8.  Elevated temperature triggers human respiratory syncytial virus F protein six-helix bundle formation.

Authors:  Abdul S Yunus; Trent P Jackson; Katherine Crisafi; Irina Burimski; Nicole R Kilgore; Dorian Zoumplis; Graham P Allaway; Carl T Wild; Karl Salzwedel
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

9.  Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection.

Authors:  Gregory H Bird; Sandhya Boyapalle; Terianne Wong; Kwadwo Opoku-Nsiah; Raminder Bedi; W Christian Crannell; Alisa F Perry; Huy Nguyen; Viviana Sampayo; Ankita Devareddy; Subhra Mohapatra; Shyam S Mohapatra; Loren D Walensky
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

10.  Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein.

Authors:  Janet L Douglas; Marites L Panis; Edmund Ho; Kuei-Ying Lin; Steve H Krawczyk; Deborah M Grant; Ruby Cai; Swami Swaminathan; Tomas Cihlar
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.